Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that effectively managing PCOS requires a multifaceted approach.

Hirsutism treatment should focus more on patient needs and quality of life.

Pubertal acne is linked to hormonal changes, affects quality of life, and is treated similarly to adult acne.

Women with PCOS often have metabolic issues like insulin resistance and a higher risk of diabetes and abnormal lipid levels.

Women with PCOS often have insulin resistance, abnormal lipid levels, and a higher risk of diabetes and heart disease; lifestyle changes and medication like metformin can help manage these risks.

White hirsute women with PCOS have higher insulin resistance, but similar nitric oxide and fibrinogen levels compared to those with idiopathic hirsutism.

Ustekinumab significantly improved sexual function and quality of life for people with moderate to severe psoriasis.

Methotrexate treatment for rheumatoid arthritis has a serious infection rate of about two per 100 patient-years.

A woman had an allergic skin reaction to a hair loss treatment containing canrenone.

The book provides a detailed guide on managing Polycystic Ovary Syndrome and is useful for physicians.

Minoxidil helps increase hair growth and density in people with hair loss, with higher concentrations giving better results.

Women with androgenetic alopecia (hair loss) have normal prostate specific antigen levels but higher testosterone levels.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Lower nitric oxide and higher fibrinogen found in hirsute women; impaired sexual function in 22.6% of hair loss patients, linked to psoriasis severity.

Female pattern hair loss affects crown, increases with age, and has limited treatments.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

Polycystic ovary syndrome is found in 6.5% of unselected Caucasian women in Spain.

The hypothesis suggests that PCOS may start early in life due to genetic and environmental factors, influencing future reproductive and metabolic problems.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Human skin makes sexual hormones that affect hair growth, skin health, and healing; too much can cause acne and hair loss, while treatments can manage these conditions.

The document likely offers guidance on treating a woman's excessive hair growth, considering her symptoms and obesity.

Exposure to too much androgen before birth might cause polycystic ovary syndrome later in life.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Metformin is effective for treating excessive hair growth in women with PCOS and may work better than the standard treatment in some ways.

Women with PCOS have lower quality of life, especially in mental health and energy, and managing weight can help improve it.

Different types of polycystic ovary syndrome (PCOS) have varying severity, with Type I being the most severe and common.